Balancing innovation, affordability and outcomes: A new model for accessing innovative drugs

When: Jeudi 22 Juin 2017, 0h30

Where: Toronto, Vancouver, Ottawa

As Canadians, we believe in the quality of our healthcare system. We also recognize that it is challenged by fiscal constraints, inconsistent delivery, different coverage approaches, and its ability to integrate new treatments. How can Canada balance the equally important objectives of innovation, affordability and good patient outcomes, for better overall healthcare?

Around the world other countries have confronted these realities. They have sought to implement a variety of innovative solutions, ranging from pay-for-performance models for medicines to new framework agreements with industry, seeking to balance the price paid for medicines with providing timely access to the latest innovations. In Canada, we are seeing the beginnings of a move toward new approaches such as patient-centred hospital management and pay-for-performance programs.

The Public Policy Forum, in partnership with Innovative Medicines Canada and McCarthy Tétrault LLP, is convening roundtables with patient group representatives, senior government policy makers, researchers/ academics/ healthcare practitioners and industry representatives. Together, we must collaborate on how Canada can tap into leading-edge healthcare innovation while meeting the needs of a growing and aging population. The roundtables will discuss:

  • What are the priority issues and barriers to accessing innovative drugs?
  • What is needed in order to build capacity to use real-world evidence and measure value for patients and payers?
  • How can new health system model(s) be developed and implemented to bring about a balance amongst innovation, affordability and good patient outcomes?

Roundtables will be held in the following locations:


June 7, 2017

7:30 – 9:30 a.m.


June 14, 2017

11:30 – 1:30


June 22, 2017

11:30 – 1:30

Attendance is by invitation only. For more information, please contact